Ergothioneine Treatment Ameliorates the Pathological Phenotypes of Parkinson's Disease Models
Journal of Neurochemistry · 2025-07 · 169 (7)
DOI: 10.1111/jnc.70168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, online erschienen am 22.07.2025. Verfasst von Teddy J W Tng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. Hauptthemen laut MEDLINE: Ergothioneine, Neuroprotective Agents, Parkinson Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Lee Kong Chian School of Medicine, Nanyang Technological University, Tan Chin Tuan Centennial Foundation, National Medical Research Council.
Abstract (Originalsprache)
Ergothioneine (ET) is a naturally occurring thiol/thione that possesses several cytoprotective properties. Multiple studies suggest a potential neuroprotective role for ET. Here, we show in various Parkinson's disease (PD) models that ET is indeed neuroprotective. Firstly, using Drosophila genetic PD models, we demonstrated that ET treatment ameliorates the pathological phenotypes of parkin and LRRK2 PD mutant flies. This includes an improvement in their climbing score and the preservation of their dopaminergic neuronal number and mitochondrial integrity. Similarly, we observed the rescue of PD phenotypes by ET in mice treated with the Parkinsonian neurotoxin 6‐OHDA. This protective effect of ET is abolished in mice lacking OCTN1. Finally, we found that ET protects human LRRK2‐G2019S patient‐derived dopaminergic neurons from rotenone‐induced neurotoxicity; the action of ET is again OCTN1‐dependent. Collectively, our results strongly support a neuroprotective role for ET in PD and suggest that ET may be useful in the prevention and/or treatment of PD. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
- IGP-Neuroscience, Interdisciplinary Graduate Programme, Nanyang Technological University, Singapore, Singapore.
- Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Neurobiology Programme, Life Sciences Institute, Centre for Life Sciences, National University of Singapore, Singapore, Singapore.
- National Neuroscience Institute, Singapore, Singapore.
- Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
ORCID-Profile: Teddy J W Tng, Barry Halliwell
Förderung
- Lee Kong Chian School of Medicine, Nanyang Technological University
- Tan Chin Tuan Centennial Foundation
- National Medical Research Council
Zitieren
APA
Tng, T. J. W., Leow, D. M. K., Goh, G., Wang, Z., Liu, Y., Tang, R. M. Y., Lai, K. C. L., Basil, A. H., Choong, H. C., Goh, W. W. B., Cheah, I. K., Ong, W. Y., Halliwell, B., & Lim, K. L. (2025). Ergothioneine Treatment Ameliorates the Pathological Phenotypes of Parkinson's Disease Models. Journal of Neurochemistry, 169(7). https://doi.org/10.1111/jnc.70168
Vancouver
Tng TJW, Leow DMK, Goh G, Wang Z, Liu Y, Tang RMY, et al. Ergothioneine Treatment Ameliorates the Pathological Phenotypes of Parkinson's Disease Models. Journal of Neurochemistry. 2025;169(7). doi:10.1111/jnc.70168
BibTeX
@article{Tng2025,
author = {Tng, Teddy J W and Leow, Damien M K and Goh, Geraldine and Wang, Ziyin and Liu, Yanmei and Tang, Richard M Y and Lai, Kate C L and Basil, Adeline H and Choong, Huey Ching and Goh, Wilson W B and Cheah, Irwin K and Ong, Wei-Yi and Halliwell, Barry and Lim, Kah-Leong},
title = {Ergothioneine Treatment Ameliorates the Pathological Phenotypes of Parkinson's Disease Models},
journal = {Journal of Neurochemistry},
year = {2025},
volume = {169},
number = {7},
doi = {10.1111/jnc.70168}
}
EUVIMED